FASN and neoplasm: In this regard it is noteworthy that several agents have been proposed for use in combination therapy for the treatment of a wide range of tumours that either directly (e.g. through administration of etomoxir) or indirectly (e.g. via the administration of fatty acid synthase inhibitors) inhibit CPT-I [46], [47].